AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $602,000 | -97.5% | 31,334 | -96.1% | 0.00% | -95.7% |
| Q2 2019 | $23,664,000 | -63.0% | 800,808 | -40.5% | 0.02% | -63.5% |
| Q1 2019 | $63,887,000 | +49.5% | 1,344,999 | +13.6% | 0.06% | +31.2% |
| Q4 2018 | $42,723,000 | -49.9% | 1,183,461 | -14.6% | 0.05% | -39.2% |
| Q3 2018 | $85,321,000 | -3.6% | 1,386,211 | +5.8% | 0.08% | -8.1% |
| Q2 2018 | $88,478,000 | +8.6% | 1,309,821 | -12.8% | 0.09% | +6.2% |
| Q1 2018 | $81,462,000 | -2.2% | 1,501,595 | +7.8% | 0.08% | -1.2% |
| Q4 2017 | $83,254,000 | -8.9% | 1,393,373 | -25.9% | 0.08% | -12.8% |
| Q3 2017 | $91,349,000 | -7.8% | 1,879,613 | -0.3% | 0.09% | -10.5% |
| Q2 2017 | $99,061,000 | -30.3% | 1,885,075 | -39.9% | 0.10% | -31.4% |
| Q1 2017 | $142,168,000 | +9.5% | 3,134,916 | -8.6% | 0.15% | +5.5% |
| Q4 2016 | $129,782,000 | -3.5% | 3,428,860 | -3.8% | 0.14% | 0.0% |
| Q3 2016 | $134,515,000 | +105.9% | 3,564,245 | -4.0% | 0.14% | +101.4% |
| Q2 2016 | $65,326,000 | +45.6% | 3,711,695 | +0.6% | 0.07% | +53.2% |
| Q1 2016 | $44,873,000 | -49.5% | 3,690,190 | +1.0% | 0.05% | -46.0% |
| Q4 2015 | $88,926,000 | +33.2% | 3,652,010 | -3.0% | 0.09% | +27.9% |
| Q3 2015 | $66,774,000 | +22.2% | 3,764,019 | +21.6% | 0.07% | +36.0% |
| Q2 2015 | $54,625,000 | -41.5% | 3,094,909 | +3.8% | 0.05% | -41.9% |
| Q1 2015 | $93,431,000 | +35.1% | 2,981,201 | +25.8% | 0.09% | +32.3% |
| Q4 2014 | $69,168,000 | +1342.8% | 2,369,583 | +922.6% | 0.06% | +1525.0% |
| Q3 2014 | $4,794,000 | -16.3% | 231,725 | +0.1% | 0.00% | -20.0% |
| Q2 2014 | $5,731,000 | +4.9% | 231,387 | -10.2% | 0.01% | 0.0% |
| Q1 2014 | $5,461,000 | +18.4% | 257,712 | +0.3% | 0.01% | 0.0% |
| Q4 2013 | $4,613,000 | – | 256,864 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |